Generic diabetes pill matches brand in body absorption test
NCT ID NCT07479108
First seen Mar 21, 2026 · Last updated May 18, 2026 · Updated 9 times
Summary
This study tested whether a generic version of empagliflozin (25 mg) works the same as the brand-name drug Jardiance® in 32 healthy adults. Participants took a single dose of each tablet under fasting conditions, and researchers measured drug levels in the blood to check for bioequivalence. The goal was to confirm the generic is a suitable alternative, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOEQUIVALANCE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
FS Scientia Pharma
San Luis Potosí City, San Luis Potosí, 78270, Mexico
Conditions
Explore the condition pages connected to this study.